These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11109505)

  • 21. Triflusal versus oral anticoagulation for primary prevention of thromboembolism after bioprosthetic valve replacement (trac): prospective, randomized, co-operative trial.
    Aramendi JI; Mestres CA; Martinez-León J; Campos V; Muñoz G; Navas C
    Eur J Cardiothorac Surg; 2005 May; 27(5):854-60. PubMed ID: 15848326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormally short activated partial thromboplastin time values are associated with increased risk of recurrence of venous thromboembolism after oral anticoagulation withdrawal.
    Legnani C; Mattarozzi S; Cini M; Cosmi B; Favaretto E; Palareti G
    Br J Haematol; 2006 Jul; 134(2):227-32. PubMed ID: 16846482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invasive procedures in the outpatient setting: managing the short-acting acenocoumarol and the long-acting phenprocoumon.
    van Geest-Daalderop JH; Hutten BA; Péquériaux NC; de Vries-Goldschmeding HJ; Räkers E; Levi M
    Thromb Haemost; 2007 Oct; 98(4):747-55. PubMed ID: 17938797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The efficacy and safety of acenocoumarol and warfarin therapy in patients with lower limb deep vein thrombosis].
    Bernát SI; Rókusz L
    Orv Hetil; 2012 May; 153(20):786-90. PubMed ID: 22580505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. D-dimer testing to determine the duration of anticoagulation therapy.
    Palareti G; Cosmi B; Legnani C; Tosetto A; Brusi C; Iorio A; Pengo V; Ghirarduzzi A; Pattacini C; Testa S; Lensing AW; Tripodi A;
    N Engl J Med; 2006 Oct; 355(17):1780-9. PubMed ID: 17065639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the safety and efficacy of oral anticoagulation for the treatment of venous thromboembolic disease in patients with or without malignancy.
    Palareti G; Legnani C; Lee A; Manotti C; Hirsh J; D'Angelo A; Pengo V; Moia M; Coccheri S
    Thromb Haemost; 2000 Nov; 84(5):805-10. PubMed ID: 11127860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study.
    Siragusa S; Malato A; Saccullo G; Iorio A; Di Ianni M; Caracciolo C; Coco LL; Raso S; Santoro M; Guarneri FP; Tuttolomondo A; Pinto A; Pepe I; Casuccio A; Abbadessa V; Licata G; Battista Rini G; Mariani G; Di Fede G
    Am J Hematol; 2011 Nov; 86(11):914-7. PubMed ID: 21953853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of thrombophilia in deciding on the duration of anticoagulation.
    Bauer KA
    Semin Thromb Hemost; 2004 Dec; 30(6):633-7. PubMed ID: 15630669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between maintenance dosages of three vitamin K antagonists: acenocoumarol, warfarin and phenprocoumon.
    van Leeuwen Y; Rosendaal FR; van der Meer FJ
    Thromb Res; 2008; 123(2):225-30. PubMed ID: 18407321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low molecular weight heparin (nadroparine) versus oral anticoagulant (acenocoumarol) in the long-term treatment of deep venous thrombosis: comparison of efficacy, safety and hospitalisation period in 105 patients.
    Mazokopakis EE; Vrentzos GE; Ganotakis ES
    Curr Med Res Opin; 2003; 19(6):565-6. PubMed ID: 14594529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Duration of antivitamin K therapy in venous thromboembolic disease].
    Ferrari E; Baudouy M; Morand P
    Arch Mal Coeur Vaiss; 1995 Dec; 88(12):1891-4. PubMed ID: 8729371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The predictive value of D-dimer measurement for cancer in patients with deep vein thrombosis.
    Schutgens RE; Beckers MM; Haas FJ; Biesma DH
    Haematologica; 2005 Feb; 90(2):214-9. PubMed ID: 15710574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 6 versus 30 months anticoagulation for recurrent venous thrombosis in patients with high factor VIII.
    Eischer L; Gartner V; Schulman S; Kyrle PA; Eichinger S;
    Ann Hematol; 2009 May; 88(5):485-90. PubMed ID: 18931845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. D-dimer levels, constitutional thrombophilia, and venous thrombosis prediction: clinical aspects and implications.
    Samama MM; Horellou MH; Elalamy I; Mathieux V; Ombandza-Moussa E; Conard J
    Semin Vasc Med; 2005 Nov; 5(4):371-4. PubMed ID: 16302158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
    van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
    Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term management of patients after venous thromboembolism.
    Kearon C
    Circulation; 2004 Aug; 110(9 Suppl 1):I10-8. PubMed ID: 15339876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment for overdose of oral anticoagulants].
    Lourenço DM; Morelli VM; Vignal CV
    Arq Bras Cardiol; 1998 Jan; 70(1):9-13. PubMed ID: 9629681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism.
    Le Gal G; Righini M; Roy PM; Sanchez O; Aujesky D; Perrier A; Bounameaux H
    Arch Intern Med; 2006 Jan; 166(2):176-80. PubMed ID: 16432085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double-blind randomized study.
    Tardy B; Tardy-Poncet B; Laporte-Simitsidis S; Mismetti P; Decousus H; Guyotat D; Bertrand JC
    Br J Haematol; 1997 Jan; 96(1):174-8. PubMed ID: 9012705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.